Reproductive Health

DigiD8 Co-Founder Barghavi Govindarajan: “I would advise fellow entrepreneurs to inculcate a bias for action and move as quickly as possible when navigating ambiguity.”

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share DigiD8’s founding story as told by co-founder Barghavi Govindarajan. DigiD8‘s mission…

The New York Academy of Medicine Launches New Initiative Focused on Maternal and Child Health

Building on its 173-year history of advancing medicine, science and public health, The New York Academy of Medicine (NYAM) has announced its convening of NYC and national experts to advance research and policy change for maternal and child health equity. NYAM recently launched a 13-member Women’s Health Research & Well-being Workgroup, and on January 12, 2021 will host a virtual Maternal and Child…

Willow Reveals Third Generation Breast Pump at CES: When Will It Be Available?

Earlier today Willow, the femtech company that changed the way women pump with the first quiet, all-in-one, in-bra wearable breast pump, announced Willow Generation 3, the most advanced model yet, will be available this spring.  The next iteration of Willow’s life-changing breast pump features groundbreaking technology that reinforces their commitment to create the smartest and most productive pumping experience for moms. In testing,…

Nuvo Announces Axia Women’s Health as First in the U.S. to Conduct FDA-cleared Remote Fetal Wellness Checks

Earlier today Nuvo announced today that for the first time, expectant mothers in the U.S. will have access to INVU, a remote monitoring platform that enables virtual fetal wellness check-ins with their doctors from any location. INVU, an FDA-cleared, prescription-initiated device will be accessible through a commercialization agreement between Nuvo and Axia Women’s Health, a women’s health network of more than 400 providers…

FPA Women’s Health Adopts NextGen Healthcare’s Patient Experience Platform to Ensure Continuity of Care During COVID-19

NextGen Healthcare, a provider of ambulatory-focused technology solutions, announced that its integrated NextGen Patient Experience Platform has been adopted by FPA Women’s Health, a mid-sized specialty medical group focused on women’s healthcare, to provide continuity of care during the COVID-19 pandemic. Since the practice’s inception in 1969, Family Planning Associates Medical Group, now FPA Women’s Health, has been providing the highest standard of medical care…

OvaryIt Launches Telehealth Platform to Help Women Choose the Right Contraception

Earlier this week OvaryIt announced the launch of its OvaryIt platform to provide telehealth solutions for women seeking focused specialty care related to hormonal and non-hormonal contraception. Using OvaryIt’s network of independent physicians and its proprietary platform (using the latest cryptographic safety and privacy features), women can safely and confidently engage through a telehealth interface.  From the moment you first log in,…

Kegg’s Kristina Cahojova: “Tenacity is your business card. “

In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share kegg‘s founding story as told by founder Kristina Cahojova. kegg’s mission…

Rhia Ventures Invests in OCON Healthcare’s Ballerine, the First 3D Spherical Copper Intrauterine Contraceptive

Rhia Ventures has invested in Israel-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUB (Intrauterine Ball). Ballerine’s unique shape reduces irritation to the endometrium with fewer malpositions and perforations, which are significant drawbacks associated with current T-shaped IUDs. The financing will also help expand Phase II clinical trials for OCON’s SEAD product, which offers point-of-care…